Heliopolis University
27 imported, source-linked research records. Open-access records.
27 matching research records
Only records linked to Heliopolis University are included. Historical ingestion is still running; these are imported records, not a count of all research worldwide.
Showing 1–27 of 27 matching records. Counts update as records arrive.
Neuroprotective plant-derived compounds via their anti-cholinesterase activity: Therapeutic potential in Alzheimer's disease
September 14, 2026 · 0 citations · Open access
Open original record →Serum Tumor Necrosis Alpha Response to aerobic Exercise Versus Added Sugar Elimination in Obese Sedentary Females
August 17, 2026 · 0 citations · Open access
Open original record →Unraveling potent therapeutic potentials of tanshinones, lipophilic abietane diterpenes: a holistic literature review
July 20, 2026 · 0 citations · Open access
Open original record →A comprehensive review of ischemic heart disease: pathophysiology, current treatments, natural products-based therapies, and nanotherapeutics
June 4, 2026 · 0 citations · Open access
Open original record →An integrative neuropharmacological review of Huntington’s disease challenges and the role of novel formulations in addressing pharmacological‒pharmaceutical limitations
May 7, 2026 · 7 citations · Open access
Open original record →Fasting safely during Ramadan with diabetes: clinical practice recommendations for Arab populations from the Arab Diabetes Forum (FSR—ADF)
April 23, 2026 · 1 citations · Open access
Open original record →Vitamin D Predicts Synopsis of Fatigue and Quality of Life in Advanced Cancer
April 4, 2026 · 0 citations · Open access
Open original record →Skeletal Muscle Disorders: Navigating Management and Natural Products
February 1, 2026 · 1 citations · Open access
Open original record →Impact of endoplasmic reticulum (ER) stress on cellular functions and role of natural products as modulators
January 26, 2026 · 3 citations · Open access
Open original record →Viniferin and its derivatives: a comprehensive review of structural variations and promising pharmacological applications in disease prevention and therapeutic development
November 29, 2025 · 2 citations · Open access
Open original record →EPHA5 and SOD2 genetic variants and their link to neurofilament light chain: early detection of taxane-induced neurotoxicity in Egyptian breast cancer patients
June 20, 2025 · 0 citations · Open access
Open original record →A comprehensive review of the impact of natural products in preventing drug-induced ototoxicity
May 8, 2025 · 2 citations · Open access
Open original record →Deciphering the mysteries of MEG3 LncRNA and its implications in genitourinary cancers
April 2, 2025 · 14 citations · Open access
Open original record →Unveiling metabolome heterogeneity in three species from Coccoloba and Ruprechtia through multiple approaches of UPLC/HRMS and chemometric analysis in relation to antidiabetic, antioxidant and antiglycation activities
March 11, 2025 · 0 citations · Open access
Open original record →Targeted Therapies: The Role of Monoclonal Antibodies in Disease Management
January 30, 2025 · 8 citations · Open access
Open original record →Targeting the SIRT3/MnSOD and JNK/HMGB1/Beclin 1 Axes: Role of Apigenin in Multifaceted Metabolic Intervention in Colorectal Cancer
December 18, 2024 · 9 citations · Open access
Open original record →Pectin nanoparticles loaded with nitric oxide donor drug: A potential approach for tissue regeneration
April 2, 2024 · 7 citations · Open access
Open original record →Decoding the secrets of longevity: unraveling nutraceutical and miRNA-Mediated aging pathways and therapeutic strategies
March 28, 2024 · 16 citations · Open access
Open original record →Linagliptin, a DPP ‐4 inhibitor, activates AMPK / FOXO3a and suppresses NFκB to mitigate the debilitating effects of diethylnitrosamine exposure in rat liver: Novel mechanistic insights
February 14, 2024 · 6 citations · Open access
Open original record →Different Continuous Training Intensities Improve Echocardiographic Parameters, Quality of Life, and Functional Capacity in Heart Failure Patients with Reduced Ejection Fraction
August 1, 2023 · 4 citations · Open access
Open original record →Taurine upregulated 1: Prognostic biomarker in breast cancer
December 1, 2022 · 0 citations · Open access
Open original record →Metabolic/hypoxial axis predicts tamoxifen resistance in breast cancer
September 27, 2022 · 10 citations · Open access
Open original record →Rosuvastatin and co-enzyme Q10 improve high-fat and high-fructose diet-induced metabolic syndrome in rats via ameliorating inflammatory and oxidative burden
August 12, 2022 · 12 citations · Open access
Open original record →Peer Review Report For: The effect of morning versus evening administration of empagliflozin on its pharmacokinetics and pharmacodynamics characteristics in healthy adults: a two-way crossover, non-randomised trial [version 1; peer review: 2 approved, 1 approved with reservations]
May 28, 2021 · 0 citations · Open access
Open original record →Peer Review Report For: The effect of morning versus evening administration of empagliflozin on its pharmacokinetics and pharmacodynamics characteristics in healthy adults: a two-way crossover, non-randomised trial [version 1; peer review: 2 approved, 1 approved with reservations]
May 28, 2021 · 0 citations · Open access
Open original record →Peer Review Report For: The effect of morning versus evening administration of empagliflozin on its pharmacokinetics and pharmacodynamics characteristics in healthy adults: a two-way crossover, non-randomised trial [version 1; peer review: 2 approved, 1 approved with reservations]
May 12, 2021 · 0 citations · Open access
Open original record →The effect of morning versus evening administration of empagliflozin on its pharmacokinetics and pharmacodynamics characteristics in healthy adults: a two-way crossover, non-randomised trial
April 26, 2021 · 7 citations · Open access
Open original record →